Hospitals have long relied on sliding scales to manage glycemic control in hospitalized patients who are not in intensive care, but significant evidence shows there is a much safer and effective approach: basal-bolus subcutaneous insulin therapy.

EndoTool SubQ offers a streamlined solution to aid providers with physiologic insulin therapy. Using a non-linear dosing model and machine-learning approach, EndoTool SubQ is a true precision medicine tool that provides clinical decision support for any situation where subcutaneous insulin is administered.

Download the brochure to see EndoTool SubQ’s features and benefits.